会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • COMPOSITIONS COMPRISING BONE MARROW CELLS, DEMINERALIZED BONE MATRIX AND RTG POLYMERS FOR USE IN THE INDUCTION OF BONE AND CARTILAGE FORMATION
    • 包含骨髓细胞,脱骨骨基质和RTG聚合物的组合物用于诱导骨和骨形成
    • WO2004022120A1
    • 2004-03-18
    • PCT/IL2002/000736
    • 2002-09-04
    • YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEMHADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD.SLAVIN, ShimonGUREVITCH, OlgaKURKALLI, Basan Gowda, S.COHN, DanielSOSNIK, Alejandro
    • SLAVIN, ShimonGUREVITCH, OlgaKURKALLI, Basan Gowda, S.COHN, DanielSOSNIK, Alejandro
    • A61L27/38
    • A61L27/3645A61K35/28A61K35/32A61K38/1875A61L27/227A61L27/26A61L27/3608A61L27/3821A61L27/3834A61L27/3843A61K2300/00
    • A composition comprising bone marrow cells (BMC) and demineralized bone matrix (DBM) or demineralized tooth matrix (DTM), together with a reverse thermogelating polymer (RTG), optionally further comprising bone morphogenetic protein/s (BMP) and/or other active agents, particularly for use in the transplantation of mesenchymal progenitor cells into a joint or a cranio-facial-maxillary bone, alveolar bone of maxilla and mandibula, spine, pelvis or long bones, or for construction or reconstruction of any extra skeletal bone, including for mechanical or biological support of artificial implants to the joint or of the joint or to the bone, for restoring and/or enhancing the formation of a new hyaline cartilage and subchondral bone structure.The BMC-DBM-RTG composition of the invention may be used for the treatment of hereditary or acquired bone disorders, hereditary or acquired cartilage disorders, primary or secondary malignant bone or cartilage disorders, metabolic bone diseases, or lesions caused by trauma, infection, any inflammatory process due to unknown or autoimmune etiology, conditions involving bone or cartilage deformities and Paget's disease. The composition may further be used for the correction of complex fractures, bone replacement and formation of new bone in plastic or sexual surgery, for support of implants of joints, cranio-facial-maxillary bones, or other musculoskeletal implants, including any artificial or musculoskeletal implants. The composition may further be used for treating damaged joints or degenerative arthropathy associated with malformation and/or dysfunction of cartilage, subchondral, and/or any other part of the bone.A kit is provided for performing transplantation of the composition into a joint, maxillary or mandibular alveolar bone or any bony structure of a mammal, including support of artificial implants.
    • 包含骨髓细胞(BMC)和脱矿质骨基质(DBM)或脱矿质牙质基质(DTM)的组合物,以及反向热凝胶聚合物(RTG),任选地还包含骨形态发生蛋白(BMP)和/或其它活性物质 特别是用于将间充质祖细胞移植到关节或头颅面上颌骨,上颌骨和下颌骨,脊柱,骨盆或长骨的牙槽骨中,或用于构建或重建任何额外的骨骼骨,包括 用于人造植入物对关节或关节或骨骼的机械或生物支持,用于恢复和/或增强新型透明软骨和软骨下骨结构的形成。本发明的BMC-DBM-RTG组合物可以是 用于治疗遗传性或获得性骨骼疾病,遗传性或获得性软骨疾病,原发性或继发性恶性骨或软骨疾病,代谢性骨疾病或病变 由于创伤,感染,由于未知或自身免疫性病因引起的任何炎症过程,涉及骨或软骨畸形的病症和佩吉特氏病引起。 组合物还可用于矫正复合骨折,骨替代和塑性或性手术中新骨形成,以支持关节植入物,颅面上颌骨或其他肌骨骼植入物,包括任何人造骨骼或肌肉骨骼 植入物。 该组合物还可用于治疗与软骨,软骨下和/或骨的任何其他部分的畸形和/或功能障碍相关的损伤关节或退行性关节病。提供用于将组合物移植到关节中的试剂盒,上颌骨 或下颌骨牙槽骨或哺乳动物的任何骨结构,包括人造植入物的支撑。
    • 3. 发明申请
    • COMPOSITIONS COMPRISING BONE MARROW CELLS TOGETHER WITH DEMINERALIZED AND/OR MINERALIZED BONE MATRIX AND USES THEREOF IN THE INDUCTION OF BONE AND CARTILAGE FORMATION
    • 包含骨髓基质细胞与成骨细胞和/或矿化骨骼基质的组合物及其在诱导骨骼和骨髓形成中的用途
    • WO2002070023A2
    • 2002-09-12
    • PCT/IL2002/000172
    • 2002-03-05
    • HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD.SLAVIN, ShimonGUREVITCH, OlgaKURKALLI, Basan, Gowda, S.PRIGOZHINA, Tatyana
    • SLAVIN, ShimonGUREVITCH, OlgaKURKALLI, Basan, Gowda, S.PRIGOZHINA, Tatyana
    • A61L
    • A61K35/32A61K35/28A61K38/1875A61K2300/00
    • A composition comprising bone marrow cells (BMC) and demineralized bone matrix (DBM) and/or mineralized bone matrix (MBM) and optionally comprising bone morphogenetic protein/s (BMP) and/or other active agents, particularly for use in the transplantation of mesenchymal progenitor cells into a joint and/or a cranio-facial-maxillary bone, for restoring and/or enhancing the formation of a new hyaline cartilage and subchondral bone structure. The composition of the invention and method of treatment employing the same may be used for the treatment of hereditary or acquired bone disorders, hereditary or acquired cartilage disorders, malignant bone or cartilage disorders, metabolic bone diseases, bone infections, conditions involving bone or cartilage deformities and Paget's disease. The composition and method may further be used for the correction of complex fractures, bone replacement and formation of new bone in plastic or sexual surgery, for support of implants of joints, cranio-facial-maxillary bones, or other musculoskeletal implants, including artificial implants. The method of the invention may further be used for treating damaged joints or degenerative arthropathy associated with malformation and/or dysfunction of cartilage and/or subchondral bone. A kit is provided for performing transplantation into a joint or a cranio-facial-maxillary bone of a mammal of the composition of the invention.
    • 包含骨髓细胞(BMC)和去矿化骨基质(DBM)和/或矿化骨基质(MBM)和任选地包含骨形态发生蛋白(BMP)和/或其他活性剂的组合物,特别是用于移植 间充质祖细胞进入关节和/或头颅面上颌骨,用于恢复和/或增强新型透明软骨和软骨下骨结构的形成。 本发明的组合物及其使用方法可用于治疗遗传性或获得性骨病,遗传性或获得性软骨疾病,恶性骨或软骨疾病,代谢性骨病,骨感染,涉及骨或软骨畸形的病症 和佩吉特病。 组合物和方法还可用于矫正复合骨折,骨替代和塑性或性手术中新骨形成,以支持关节植入物,颅面上颌骨或其他肌骨骼植入物,包括人造植入物 。 本发明的方法还可用于治疗与软骨和/或软骨下骨的畸形和/或功能障碍相关的损伤关节或退行性关节病。 提供用于进行移植到本发明组合物的哺乳动物的关节或头颅面上颌骨中的试剂盒。